Search Results - "Ganduglia Cazaban, Cecilia M."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Microcephaly inpatient hospitalization and potential Zika outbreak in Texas: A cost and predicted economic burden analysis by Shewale, Jitesh B., Ganduglia Cazaban, Cecilia M., Waller, D. Kim, Mitchell, Laura E., Langlois, Peter H., Agopian, A.J.

    Published in Travel medicine and infectious disease (01-07-2019)
    “…Estimate inpatient hospitalization costs for patients with microcephaly, and predict cost increases due to a potential Zika virus outbreak. We identified…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Describing characteristics of adults with and without congenital heart defects hospitalized with COVID‐19 by Diaz, Perla, Coughlin, Will, Lam, Wilson, Ermis, Peter, Aguilar, David, Ganduglia Cazaban, Cecilia M., Agopian, A. J.

    Published in Birth defects research (15-07-2022)
    “…Background We sought to describe patient characteristics in adults with and without congenital heart defects (CHDs) during hospitalization for COVID‐19…”
    Get full text
    Journal Article
  4. 4

    Teaching and Safety-Net Hospital Penalization in the Hospital-Acquired Condition Reduction Program by Serpa, Jose A, Gemeinhardt, Gretchen, Arias, Cesar A, Morgan, Robert O, Russell, Heidi, Miao, Hongyu, Ganduglia Cazaban, Cecilia M

    Published in JAMA network open (05-02-2024)
    “…The Hospital-Acquired Condition Reduction Program (HACRP) evaluates acute care hospitals on the occurrence of patient safety events and health care-associated…”
    Get full text
    Journal Article
  5. 5

    Achieving Adherence After First‐Line Antihypertensive Treatment: Should Fixed‐Dose Combinations Receive Priority? by Sonawane Deshmukh, Kalyani B., Qian, Jingjing, Garza, Kimberly B., Wright, Bradley M., Zeng, Peng, Ganduglia Cazaban, Cecilia M., Hansen, Richard A.

    “…Data on the long‐term outcomes of the use of fixed‐dose combinations (FDCs) or free‐pill combinations (FPCs), titration of doses, and switching are currently…”
    Get full text
    Journal Article
  6. 6

    Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation? by Sonawane, Kalyani B, Qian, Jingjing, Garza, Kimberly B, Wright, Bradley M, Zeng, Peng, Ganduglia-Cazaban, Cecilia M, Hansen, Richard A

    Published in Journal of hypertension (01-03-2016)
    “…OBJECTIVES:Treatment modifications – addition, uptitration, switching, and downtitration – are necessary to address issues such as unattained blood pressure…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Abstract P234: Stroke in Texas: Leveraging Population Level Data to Inform Public Health by Krause, Trudy M, Ganduglia-Cazaban, Cecilia M, Savitz, Sean I, Rajan, Suja S

    Published in Stroke (1970) (01-03-2021)
    “…IntroductionWe studied variation in stroke rates, post-discharge health services, and outcomes across payors in Texas. MethodsClaims for 48,331 stroke patients…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Abstract 11047: Racial Balance in Heart Failure Treatment, Use of Implantable Left Ventricular Assist Devices, and Cardiac Transplantation by Musfee, Fadi I, hamden, randa, Buddha, Mrinalini, Naizer, Hayden, Zingg Guzman, Alexandra Q, Ganduglia Cazaban, Cecilia M, Letsou, George V

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…IntroductionThe incidence of left ventricular assist device (LVAD) implantation in heart failure (HF) patients across various racial groups has not been…”
    Get full text
    Journal Article
  12. 12

    Abstract 11040: Gender Imbalance in Heart Failure Treatment, Use of Implantable Left Ventricular Assist Systems, and Cardiac Transplantation by Musfee, Fadi I, Hamden, Randa, Buddha, Mrinalini, Naizer, Hayden, Zingg Guzman, Alexandra, Cecilia, Ganduglia Cazaban M, Letsou, George V

    Published in Circulation (New York, N.Y.) (16-11-2021)
    “…IntroductionFewer women than men with heart failure (HF) progress to implantation of a left ventricular assist device (LVAD) or transplant. A comprehensive,…”
    Get full text
    Journal Article
  13. 13

    Opioid usage patterns among Medicare pancreatic cancer patients according to palliative care utilization by Lu, Zhanni, Ganduglia Cazaban, Cecilia M, LeonNovelo, Luis G., Yennu, Sriram, Giordano, Sharon H., Zhao, Hui

    Published in Journal of clinical oncology (01-11-2019)
    “…Abstract only 14 Background: Opioid pharmacotherapy is used to manage moderate and severe pain in palliative care (PC). Pain affects 80% pancreatic cancer…”
    Get full text
    Journal Article
  14. 14

    Are symptoms distinguishable in ovarian cancer? A nested case control study of insurance claims by Langabeer, Denise Manon, Krause, Trudy, Ganduglia Cazaban, Cecilia M, Swartz, Michael D, Lopez, David S, Bodurka, Diane C.

    Published in Journal of clinical oncology (20-05-2020)
    “…Abstract only 6063 Background: Over 60% of ovarian cancer cases are diagnosed with Stage III and IV disease. The US healthcare system does not support a…”
    Get full text
    Journal Article
  15. 15

    Community-based palliative care and end-of-life care in elderly patients with pancreatic cancer by Lu, Zhanni, Ganduglia Cazaban, Cecilia M, LeonNovelo, Luis G, Yennu, Sriram J., Conway, Sadie H, Highfield, Linda D, Giordano, Sharon Hermes, Zhao, Hui

    Published in Journal of clinical oncology (01-12-2018)
    “…Abstract only 70 Background: No population-based studies have evaluated the impact of community-based palliative care (CBPC) on aggressive end-of-life (EOL)…”
    Get full text
    Journal Article
  16. 16